Collectively, these studies show important roles for DNMT1 during anti-tumor immunity, but it is unknown how methylation-specific cues in other cell types in the tumor microenvironment might impact tumor immune surveillance and responses to ICB. Here, DNMT1 is linked to neoplasm.